The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.

by Jaana T Joensuu, Saara Huoponen, Kalle J Aaltonen, Yrjö T Konttinen, Dan Nordström, Marja Blom
Published 2015-01-01

Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis.

by Kalle J Aaltonen, Liisa M Virkki, Antti Malmivaara, Yrjö T Konttinen, Dan C Nordström, Marja Blom
Published 2012-01-01

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.

by Saara Huoponen, Kalle J Aaltonen, Jaana Viikinkoski, Jarno Rutanen, Heikki Relas, Kirsi Taimen, Kari Puolakka, Dan Nordström, Marja Blom
Published 2019-01-01

Enhancing flood resilience through improved risk communications

by J. J. O'Sullivan, R. A. Bradford, M. Bonaiuto, S. De Dominicis, P. Rotko, J. Aaltonen, K. Waylen, S. J. Langan
Published 2012-07-01

Comparative Genomics of 42 <i>Arcanobacterium phocae</i> Strains

by Kirsi J. Aaltonen, Ravi Kant, Nanett Kvist Nikolaisen, Mikkel Lindegaard, Mirja Raunio-Saarnisto, Lars Paulin, Olli Vapalahti, Tarja Sironen
Published 2021-06-01

Risk perception – issues for flood management in Europe

by R. A. Bradford, J. J. O'Sullivan, I. M. van der Craats, J. Krywkow, P. Rotko, J. Aaltonen, M. Bonaiuto, S. De Dominicis, K. Waylen, K. Schelfaut
Published 2012-07-01